240 related articles for article (PubMed ID: 34589275)
21. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
[TBL] [Abstract][Full Text] [Related]
22. Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells.
Guo S; Huang F; Guo P
Gene Ther; 2006 May; 13(10):814-20. PubMed ID: 16482206
[TBL] [Abstract][Full Text] [Related]
23. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
24. Strategies for improving the specificity of siRNAs for enhanced therapeutic potential.
Gatta AK; Hariharapura RC; Udupa N; Reddy MS; Josyula VR
Expert Opin Drug Discov; 2018 Aug; 13(8):709-725. PubMed ID: 29902093
[TBL] [Abstract][Full Text] [Related]
25. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
[TBL] [Abstract][Full Text] [Related]
26. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
[TBL] [Abstract][Full Text] [Related]
27. siRNA release from pri-miRNA scaffolds is controlled by the sequence and structure of RNA.
Galka-Marciniak P; Olejniczak M; Starega-Roslan J; Szczesniak MW; Makalowska I; Krzyzosiak WJ
Biochim Biophys Acta; 2016 Apr; 1859(4):639-49. PubMed ID: 26921501
[TBL] [Abstract][Full Text] [Related]
28. Principles of Dicer substrate (D-siRNA) design and function.
Amarzguioui M; Rossi JJ
Methods Mol Biol; 2008; 442():3-10. PubMed ID: 18369774
[TBL] [Abstract][Full Text] [Related]
29. Generation of siRNA Nanosheets for Efficient RNA Interference.
Kim H; Lee JS; Lee JB
Sci Rep; 2016 Apr; 6():25146. PubMed ID: 27120975
[TBL] [Abstract][Full Text] [Related]
30. Exosomes-mediated synthetic Dicer substrates delivery for intracellular Dicer imaging detection.
Dai W; Su L; Lu H; Dong H; Zhang X
Biosens Bioelectron; 2020 Mar; 151():111907. PubMed ID: 31999571
[TBL] [Abstract][Full Text] [Related]
31.
Jin K; Liao YC; Cheng TC; Li X; Lee WJ; Pi F; Jasinski D; Chen LC; Phelps MA; Ho YS; Guo P
Mol Pharm; 2024 Feb; 21(2):718-728. PubMed ID: 38214504
[TBL] [Abstract][Full Text] [Related]
32. Fabrication of Polyvalent Therapeutic RNA Nanoparticles for Specific Delivery of siRNA, Ribozyme and Drugs to Targeted Cells for Cancer Therapy.
Shu Y; Shu D; Diao Z; Shen G; Guo P
IEEE NIH Life Sci Syst Appl Workshop; 2009 May; 2009():9-12. PubMed ID: 21243099
[TBL] [Abstract][Full Text] [Related]
33. The potency of siRNA-mediated growth inhibition following silencing of essential genes is dependent on siRNA design and varies with target sequence.
Patel R; T'wallant NC; Herbert MH; White D; Murison JG; Reid G
Oligonucleotides; 2009 Dec; 19(4):317-28. PubMed ID: 19943803
[TBL] [Abstract][Full Text] [Related]
34. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
[TBL] [Abstract][Full Text] [Related]
35. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
[TBL] [Abstract][Full Text] [Related]
36. Strategies, design, and chemistry in siRNA delivery systems.
Dong Y; Siegwart DJ; Anderson DG
Adv Drug Deliv Rev; 2019 Apr; 144():133-147. PubMed ID: 31102606
[TBL] [Abstract][Full Text] [Related]
37. Bubbled RNA-Based Cargo for Boosting RNA Interference.
Kim H; Jeong J; Kim D; Kwak G; Kim SH; Lee JB
Adv Sci (Weinh); 2017 Aug; 4(8):1600523. PubMed ID: 28852615
[TBL] [Abstract][Full Text] [Related]
38. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.
De Backer L; Cerrada A; Pérez-Gil J; De Smedt SC; Raemdonck K
J Control Release; 2015 Dec; 220(Pt B):642-50. PubMed ID: 26363301
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
40. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
